Patient visits for heart attack and stroke have dropped significantly during the COVID-19 pandemic, compared to patient visits during the same period in 2019, indicating patients may be avoiding care for potentially life-threatening conditions, a new study shows.
Oncology
Prominent cancer researcher Pier Paolo Pandolfi, MD, PhD, has joined the Desert Research Institute and Renown Health, both based in Reno, Nev., the organizations announced May 18.
New York City-based Memorial Sloan Kettering Cancer Center ended the first quarter of 2020 with an operating loss, despite seeing revenue increase year over year, according to recently released financial documents.
Vaccines and anti-infectives are among the highest therapy priorities for U.S. health plans, according to a report from consulting and professional services firm ZS.
More than half of cancer researchers report that their work has been temporarily put on hold due to the coronavirus pandemic, according to a new survey.
Advertisement
A new artificial intelligence algorithm can accurately assess the risk of cancer associated with indeterminate pulmonary nodules in patients' lungs, according to a study published in American Journal of Respiratory and Critical Care Medicine.
Thomas Jefferson University will no longer purchase the Fox Chase Cancer Center from Temple University due to the "devastating economic impact of COVID-19."
The amount of Americans undergoing routine cancer screenings has plummeted during the pandemic, according to Epic data cited by STAT.
The costs of dozens of cancer drugs were about 2.3 times higher in the U.S. than in Europe even though they had similar clinical benefits, according to a study cited by STAT.